Gross Profit Trends Compared: Dr. Reddy's Laboratories Limited vs Bio-Techne Corporation

Comparing Gross Profit Trends: Dr. Reddy's vs Bio-Techne

__timestampBio-Techne CorporationDr. Reddy's Laboratories Limited
Wednesday, January 1, 201425141100075801000000
Thursday, January 1, 201530727700085403000000
Friday, January 1, 201633665900092281000000
Sunday, January 1, 201737454100078356000000
Monday, January 1, 201843214300076304000000
Tuesday, January 1, 201947349100083430000000
Wednesday, January 1, 202048319400094009000000
Friday, January 1, 2021632850000103077000000
Saturday, January 1, 2022756496000113840000000
Sunday, January 1, 2023769815000202972000000
Monday, January 1, 2024769725000163607000000
Loading chart...

Unlocking the unknown

Gross Profit Trends: A Tale of Two Companies

In the ever-evolving landscape of the pharmaceutical and biotechnology sectors, Dr. Reddy's Laboratories Limited and Bio-Techne Corporation stand as prominent players. Over the past decade, Dr. Reddy's has consistently outperformed Bio-Techne in terms of gross profit, showcasing a robust growth trajectory. From 2014 to 2023, Dr. Reddy's gross profit surged by approximately 167%, peaking in 2023. In contrast, Bio-Techne's growth, while steady, was more modest, with a 206% increase over the same period.

Key Insights

  • Dr. Reddy's Laboratories Limited: Demonstrated a significant upward trend, with gross profits reaching their zenith in 2023.
  • Bio-Techne Corporation: Experienced a gradual increase, with notable growth in the latter half of the decade.

This comparison highlights the dynamic nature of these industries and the strategic maneuvers companies must undertake to maintain competitive advantage.

Published by
U.S. Securities and Exchange Commission

Source link
sec.gov

Date published
17 Jan 2025